Exterro to Lead the Conversation on AI, Risk, and the Future of eDiscoveryPORTLAND, Ore., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Exterro today announced that the 11th annual eDiscovery Day will take place ...
A federal judge in Chicago on Wednesday agreed to keep a restraining order barring the Trump administration from deploying ...
Once-weekly semaglutide 2.4 mg conferred a greater reduction in major adverse cardiovascular events than placebo, regardless ...
NT-0796 is an oral, brain-penetrant NLRP3 inhibitor that selectively regulates chronic inflammation, a key driver of cardiometabolic diseases ...
The oral argument Monday in Berk v. Choy was filled with the nuts and bolts of judicial procedure – what it takes to get a ...
Cryptopolitan on MSN
Rivian agrees to a $250M legal settlement over IPO price fraud
EV automaker Rivian has agreed to pay $250 million to settle a 2022 class-action lawsuit over alleged IPO underpricing fraud.
After a federal judge tossed President Donald Trump’s disparagement lawsuit filed in September against the New York Times and ...
Heart disease remains the leading cause of death for women worldwide, but women have historically been underrepresented in ...
Shady Canyon Golf Club Inc. in Irvine, Calif., secured dismissal of a whistleblower’s False Claims Act suit accusing the club ...
A federal judge tossed Shante Kelly’s sexual assault suit against Diddy, citing vague details but allowing her to refile by ...
A new class of search tools is redefining what’s possible—allowing a shift from a “search results” paradigm to one based on ...
Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically meaningful improvement for the dual pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback